We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ERS Genomics Licenses Genome-Editing Patents to Regeneron Pharmaceuticals

News   Nov 26, 2015

 
ERS Genomics Licenses Genome-Editing Patents to Regeneron Pharmaceuticals
 
 
 

RELATED ARTICLES

A Way to Enhance Adsorption of Chemotherapy Drugs

News

A new study demonstrates adsorption of chemotherapy drugs onto active carbon delivery capsule can be enhanced with aluminium atom inclusions.

READ MORE

CRISPR Screen Identifies Gene That Helps Cells Resist West Nile, Zika Viruses

News

CRISPR used to identify a gene which helps cells resist a nasty class of pathogens.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE